Basics |
Company: |
Gilead Sciences, Inc. |
IPO Date: |
January 3, 1994 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$137B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.72 | 1.13%
|
Avg Daily Range (30 D): |
$0.99 | 1.01%
|
Avg Daily Range (90 D): |
$0.91 | 0.98%
|
Institutional Daily Volume |
Avg Daily Volume: |
12.08M |
Avg Daily Volume (30 D): |
5.82M |
Avg Daily Volume (90 D): |
4.9M |
Trade Size |
Avg Trade Size (Sh.): |
233 |
Avg Trade Size (Sh.) (30 D): |
74 |
Avg Trade Size (Sh.) (90 D): |
70 |
Institutional Trades |
Total Inst.Trades: |
118,149 |
Avg Inst. Trade: |
$5M |
Avg Inst. Trade (30 D): |
$9.5M |
Avg Inst. Trade (90 D): |
$10.24M |
Avg Inst. Trade Volume: |
.12M |
Avg Inst. Trades (Per Day): |
21 |
Market Closing Trades |
Avg Closing Trade: |
$52.56M |
Avg Closing Trade (30 D): |
$119.85M |
Avg Closing Trade (90 D): |
$117.47M |
Avg Closing Volume: |
830.08K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$.11
|
$1
|
$1.29
|
Diluted EPS
|
$.09
|
$1
|
$1.29
|
Revenue
|
$ 28.3B
|
$ 7.55B
|
$ 6.95B
|
Gross Profit
|
$ 21.54B
|
$ 5.97B
|
$ 5.41B
|
Net Income / Loss
|
$ 114M
|
$ 1.25B
|
$ 1.61B
|
Operating Income / Loss
|
$ 822M
|
$ 888M
|
$ 2.64B
|
Cost of Revenue
|
$ 6.76B
|
$ 1.57B
|
$ 1.54B
|
Net Cash Flow
|
$ -669M
|
$ 2.26B
|
$ -1946M
|
PE Ratio
|
1,221.11
|
|
|
Splits |
Jan 28, 2013:
1:2
|
Jun 25, 2007:
1:2
|
Sep 07, 2004:
1:2
|
Mar 08, 2002:
1:2
|
Feb 22, 2001:
1:2
|
|